Advances in the Discovery of CC Chemokine Receptor 2 Antagonists

被引：20
作者：
Carter, Percy H. [1 ]
Cherney, Robert J. [1 ]
Mangion, Ian K. [1 ]
机构：
[1] Bristol Myers Squibb Co, Res & Dev, Princeton, NJ 08543 USA
来源：
ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 42 | 2007年 / 42卷
关键词：
D O I：
10.1016/S0065-7743(07)42014-0
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
[No abstract available]
引用
收藏
页码：211 / 227
页数：17
相关论文
共 122 条
[51]  
GOBLE SD, 2006, Patent No. 060069088
[52]  
GOBLE SD, 2004, Patent No. 04092124
[53]  
GOBLE SD, 2005, Patent No. 05067502
[54]   Monocyte and macrophage heterogeneity [J].
Gordon, S ;
Taylor, PR .
NATURE REVIEWS IMMUNOLOGY, 2005, 5 (12) :953-964
[55]   The presence of leukocyte CC-chemokine receptor 2 in CCR2 knockout mice promotes atherogenesis [J].
Guo, J ;
Van Eck, M ;
de Waard, V ;
Maeda, N ;
Benson, GM ;
Groot, PHE ;
Van Berkel, TJC .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2005, 1740 (03) :453-459
[56]   Repopulation of apolipoprotein E knockout mice with CCR2-deficient bone marrow progenitor cells does not inhibit ongoing atherosclerotic lesion development [J].
Guo, J ;
de Waard, V ;
Van Eck, M ;
Hildebrand, RB ;
van Wanrooij, EJA ;
Kuiper, J ;
Maeda, N ;
Benson, GM ;
Groot, PHE ;
Van Berkel, TJC .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2005, 25 (05) :1014-1019
[57]   Transplantation of monocyte CC-chemokine receptor 2-deficient bone marrow into ApoE3-Leiden mice inhibits atherogenesis [J].
Guo, J ;
Van Eck, M ;
Twisk, J ;
Maeda, N ;
Benson, GM ;
Groot, PHE ;
Van Berkel, TJC .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2003, 23 (03) :447-453
[58]   A randomized controlled trial with an anti-CCL2 (anti-monocyte chemotactic protein 1) monoclonal antibody in patients with rheumatoid arthritis [J].
Haringman, Jasper J. ;
Gerlag, Danielle M. ;
Smeets, Tom J. M. ;
Baeten, Dominique ;
Van den Bosch, Filip ;
Bresnihan, Barry ;
Breedveld, Ferdinand C. ;
Dinant, Huib J. ;
Legay, Francois ;
Gram, Hermann ;
Loetscher, Pius ;
Schmouder, Robert ;
Woodworth, Thasia ;
Tak, Paul P. .
ARTHRITIS AND RHEUMATISM, 2006, 54 (08) :2387-2392
[59]   Antagonist of monocyte chemoattractant protein 1 ameliorates the initiation and progression of lupus nephritis and renal vasculitis in MRL/lpr mice [J].
Hasegawa, H ;
Kohno, M ;
Sasaki, M ;
Inoue, A ;
Ito, MR ;
Terada, M ;
Hieshima, K ;
Maruyama, H ;
Miyazaki, JI ;
Yoshie, O ;
Nose, M ;
Fujita, S .
ARTHRITIS AND RHEUMATISM, 2003, 48 (09) :2555-2566
[60]  
Hersperger R., 2005, Patent No. [2005077932 A2, 2005077932]
12345678910